Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-40929837 in Mild Atopic Asthma
NCT01241422Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of JNJ-40929837 in asthma, sponsored by Johnson & Johnson. Started Nov 2010; status: completed.
02
Drugs
JNJ-40929837
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01241422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241422.